Journals / Dicle Tıp Dergisi / 2016 / Cilt: 43 - Sayı: 3

Thyroid Malignancies In Patients With Graves' Disease

Graves' Hastalığına Sahip Olgularda Tiroid Maligniteleri

Pages
460–467
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The prevalence of malignancy was significantly higher in cases of Graves' disease with macroscopic or microscopic nodule than in Graves' patients without nodule (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Graves' disease is an autoimmune thyroid disorder.
📊
Key Findings & Data:Methods: The slides of forty patients, which underwent thyroidectomy due to Graves' disease, were reevaluated in between 2010 to 2016.Results: 11 of 40 thyroidectomy specimens (27.5%) had primary thyroid malignancy.
💡
Conclusion & Impact:The prevalence of malignancy was significantly higher in cases of Graves' disease with macroscopic or microscopic nodule than in Graves' patients without nodule (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Graves' disease is an autoimmune thyroid disorder. Concurrent Graves' disease with primary thyroid malignancies has been reported at an increasing frequency. The aim of this study is to investigate the prevalence of primary thyroid malignancies among thyroidectomy specimens with Graves' disease examined in our department. Methods: The slides of forty patients, which underwent thyroidectomy due to Graves' disease, were reevaluated in between 2010 to 2016.Results: 11 of 40 thyroidectomy specimens (27.5%) had primary thyroid malignancy. All malignancies were papillary carcinoma. The prevalence of malignancy was significantly higher in cases of Graves' disease with macroscopic or microscopic nodule than in Graves' patients without nodule (p

Özet

Amaç: Graves' hastalığı otoimmün bir tiroid hastalığıdır. Eş zamanlı primer tiroid maligniteleri ile Graves' hastalığı birlikteliği, giderek artan bir sıklıkta bildirilmektedir. Çalışmanın amacı laboratuarımızda incelenen Graves' hastalığına sahip olguların tiroidektomi materyallerinde tiroid malignitesi sıklığını araştırmaktır.Yöntemler: 2010-2016 yılları arasında Recep Tayyip Erdoğan Üniversitesi Eğitim ve Araştırma Hastanesi Patoloji Laboratuarı'na Graves' hastalığı nedeni ile gönderilen kırk (40) adet tiroidektomi materyaline ait preparat örnekleri yeniden incelendi.Bulgular: Kırk adet tiroidektomi materyalinin 11 (%27,5) tanesinde malignite saptandı. Malignitelerin tümü papiller karsinomdu. Makroskopik ya da mikroskopik olarak nodüle sahip Graves hastalıklı olgularda malignite sıklığı, nodülü olmayan gruba göre daha yüksek bulundu (p

🔖

Cite This Article

GÜÇER, H. (2022). Thyroid Malignancies In Patients With Graves' Disease. Dicle Tıp Dergisi, Cilt: 43 - Sayı: 3, 460–467. https://ajindex.com/articles/487429

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Menconi F, Marcocci C, Marino M. Diagnosis and classification of Graves' disease. Autoimmun Rev. 2014;13:398-402
  2. Cantalamessa L, Baldini M, Orsatti A, et al. Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Arch Intern Med. 1999;159:1705-8
  3. Erbil Y, Barbaros U, Ozbey N, et al. Graves' disease, with and without nodules, and the risk of thyroid carcinoma. J Laryngol Otol. 2008;122:291-5
  4. Tam AA, Kaya C, Kilic FB, et al. Thyroid nodules and thyroid cancer in Graves' disease. Arq Bras Endocrinol Metabol. 2014;58:933-8
  5. Boutzios G, Vasileiadis I, Zapanti E et al. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease. Thyroid. 2014;24:347-54
  6. Chen YK, Lin CL, Chang YJ, et al. Cancer risk in patients with Graves' disease: a nationwide cohort study. Thyroid. 2013;23:879-84
  7. Ergin AB, Saralaya S, Olansky L. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience. Am J Otolaryngol. 2014;35:784-90
  8. Gerenova J, Buysschaert M, de Burbure CY, Daumerie C. Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. European Journal of Internal Medicine. 2003;14:321-5
  9. Lee J, Nam KH, Chung WY, et al. Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves' disease. J Korean Med Sci. 2008;23:796-801
  10. Phitayakorn R, McHenry CR. Incidental thyroid carcinoma in patients with Graves' disease. Am J Surg. 2008;195:292- 7; discussion 7
  11. Ren M, Wu MC, Shang CZ, et al. Predictive factors of thyroid cancer in patients with Graves' disease. World J Surg. 2014;38:80-7
  12. Staniforth JU, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves' disease: A meta-analysis. Int J Surg. 2016;27:118-25
  13. Tamatea JA, Tu'akoi K, Conaglen JV, et al. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease? ANZ J Surg. 2014;84:231-4
  14. Wei S, Baloch ZW, LiVolsi VA. Thyroid carcinoma in patients with Graves' disease: an institutional experience. Endocr Pathol. 2015;26:48-53
  15. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004;11:279-87
  16. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Ca